Brought to you by:
SEISMIQ IVL offers targeted approach to increasingly complex PAD
This video is sponsored by Boston Scientific. Nicolas Mouawad, MD, chief of vascular surgery at McLaren Health in Bay City, Michigan, discussed the growing challenge of treating peripheral artery disease (PAD) as an aging patient population presents with increasingly complex,…
Payment for the new LER codes: It’s not just about the work
The new Current Procedural Terminology (CPT) codes and associated values for lower extremity revascularization (LER) took effect Jan. 1, 2026. These 46 new codes represent a significant update from the last time these codes were revised in 2011. As noted…
Advancing below-the-knee intervention in CLTI with Shockwave Javelin Peripheral IVL
This advertorial is sponsored by Shockwave Medical. Charles Bailey, MD, George Adams, MD and Vanessa Adams, BS, share their experience with Shockwave Javelin, the first-of-its-kind forward intravascular lithotripsy (IVL) technology that is enabling further interventional treatment for patients suffering from…
FastWave Medical appoints principal investigators for IVL pivotal trial
Venita Chandra, MD, clinical professor of surgery at Stanford Health Care in Stanford, California, will serve as a co-principal investigator for the upcoming investigational device exemption (IDE) pivotal trial of Artero, FastWave Medical‘s peripheral electric intravascular lithotripsy (E-IVL) system. The…
Shockwave Medical announces US launch of intravascular lithotripsy catheter
Today, Shockwave Medical announced the U.S. launch of its Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter, a platform designed to modify calcium and cross narrowed vessels in patients with peripheral artery disease (PAD). The platform is designed to modify calcium…
Boston Scientific to acquire IVL developer Bolt Medical
Boston Scientific has announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease. “Representing one of the fastest growing…
Pioneering Florida limb preservation program laser-focuses on evidence-based, customized care for PAD
This advertorial is sponsored by Tampa General Hospital. As the prevalence of peripheral arterial disease (PAD) continues to climb across the U.S. and globally, a pioneering limb preservation program in south Florida is sharpening its resolve to provide cutting-edge treatment…
Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance goals in feasibility and IDE studies
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the first clinical outcomes associated with the Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter, a novel, non-balloon-based lithotripsy platform designed to modify calcium and cross extremely narrowed vessels in patients…
Bolt Medical announces completion of RESTORE ATK and RESTORE BTK pivotal studies investigating Bolt IVL system
Bolt Medical has announced the completion and results of the RESTORE ATK and RESTORE BTK pivotal clinical trials investigating the company’s Bolt intravascular lithotripsy (IVL) above-the-knee (ATK) and below-the-knee (BTK) systems for the treatment of peripheral arterial disease (PAD) in…
First patient enrolled in study of integrated laser atherectomy and IVL catheter
Royal Philips has announced enrolment of the first patient in the US THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy (IVL) catheter. Procedures that previously required the use of two different devices can…